03/24/2021
https://www.congress.gov...
"I hope that all of you as companies and advocates will also start to factor in that these drugs affect people differently."
"I think for our panel members, what you are getting is a sense of how importantly this committee regards international trade."
"if political organizations do not want to be scrutinized by the government, they should not seek privileges like tax-free status and anonymity for their donors."
"What troubles me is, on your watch, when the lines are blurring on this disclosure issue, as far as I can tell you all did not do anything to correct the problem in a meaningful way."